Business Model

The Stages of Development

Endovasc has identified promising drug candidates which may be developed as useful therapies for specific diseases within the portfolio of the company's therapies.  These drugs are then tested for proof of concept and safety.  Once these objectives are achieved, an Investigational New Drug Application (IND) is prepared and filed with the U.S. Food and Drug Administration to begin to test the drug in humans.

Once Human Clinical studies results are obtained, Endovasc will pursue organizations that have a similar interest and synergistic product pipelines to co-develop the drug toward marketing approval. 

Further development costs and commercialization may be financed by a pharmaceutical partner, while Endovasc receives long-term royalty income.

If a collaborator or co-sponsor is not identified, the intellectual property is to be packaged into an Endovasc subsidiary and funding will be secured to advance the product through further clinical trials.

Endovasc's drug candidates are currently in various stages of development.